Pediatric Insomnia in ADHD Clinical Study - Enrolling Patients

Pediatric Insomnia in ADHD Study - Mulitcenter Study

Study summary:		A randomized, placebo-controlled, double-blind, fixed-dose study of the efficacy and safety of Eszopicolone (Lunesta) in children 6-11, adolescents 12-17 with attention deficit/hyperactivity disorder- associated insomnia.
Qualified participants must:		• Have documented ADHD-associated insomnia, defined as the subject or subject's parental guardian reports difficulty with sleep latency greater than 30 min • Have daytime functional impairment as a result of sleep problems • Have tried behavioral intervention for sleep problems • Be able to stay over night in a sleep lab for testing

http://www.ClinicalConnection.com/PatientViewStudy7861.aspx

http://clinicaltrials.gov/ct2/show/NCT00856973